Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

Abstract Background This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the US, through claims data. Methods SCD patients with pharmacy claims for HU were selected from the Medicaid Analytic Extracts (MAX) from J...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nirmish Shah, Menaka Bhor, Lin Xie, Rashid Halloway, Steve Arcona, Jincy Paulose, Huseyin Yuce
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2019-10-01
Col·lecció:	Health and Quality of Life Outcomes
Matèries:	Hydroxyurea Adherence Discontinuation Health care Cost Utilization
Accés en línia:	http://link.springer.com/article/10.1186/s12955-019-1225-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!